Whether pursued through OMB guidance or a new Executive Order, the NIH grantmaking changes reportedly under consideration would significantly slow down the engine that is the U.S. biomedical research enterprise and inject political decision-making into an already rigorous vetting process for grant recipients — leaving patients out in the cold and cures out of reach.
Sep
22
Comments are closed.